Back to VOLORIDGE INVESTMENT MANAGEMENT, LLC VOLORIDGE INVESTMENT MANAGEMENT, LLC

CORTCORT

Showing 4 of 23 quarters

Position history for VOLORIDGE INVESTMENT MANAGEMENT, LLCVOLORIDGE INVESTMENT MANAGEMENT, LLC's holdings in CORCEPT THERAPEUTICS INC

No. Voloridge Investment Management exited its CORT (Corcept Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 181,571 shares worth $20.7M. Voloridge Investment Management first reported CORT in Q3 2019 and held it in 21 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$28.8M

Total Shares Change

-622,171

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$73.40
0
2025-Q1
Decreased
181,571
-61.5%
$20.7M0.1%$114.22
0
2024-Q4
Decreased
471,623
-24.2%
$23.8M0.1%$50.39
0
2024-Q3
Decreased
622,171
-19.1%
$28.8M0.1%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used